Aortic counterpulsation: A review of the hemodynamic effects and indications for use

Catheterization and Cardiovascular Interventions

Volumn 67, Issue 1, 2006, Pages 68-77

  Santa Cruz, Richard A ^a   Cohen, Mauricio G ^a   Ohman, E Magnus ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

Acute myocardial infarction; Aortic counterpulsation; Cardiogenic shock; Coronary artery disease; Coronary revascularization

Indexed keywords

ANTICOAGULANT AGENT; HEPARIN;

ACUTE HEART INFARCTION; AORTA BALLOON; AORTIC COUNTERPULSATION; ARTERY INJURY; BLEEDING; CARDIOGENIC SHOCK; CLINICAL TRIAL; CORONARY ARTERY BLOOD FLOW; COUNTERPULSATION; DEVICE; DIASTOLIC BLOOD PRESSURE; HEART AFTERLOAD; HEART ARRHYTHMIA; HEART SURGERY; HEART TRANSPLANTATION; HEMODYNAMICS; HIGH RISK PATIENT; HUMAN; INTENSIVE CARE; OFF PUMP CORONARY SURGERY; PATIENT SELECTION; PRACTICE GUIDELINE; REVIEW; TREATMENT CONTRAINDICATION; TREATMENT INDICATION; UNSTABLE ANGINA PECTORIS;

ANGINA, UNSTABLE; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; BLOOD PRESSURE; CORONARY CIRCULATION; HEART TRANSPLANTATION; HUMANS; INTRA-AORTIC BALLOON PUMPING; MYOCARDIAL INFARCTION; SHOCK, CARDIOGENIC;

EID: 30344471501     PISSN: 15221946     EISSN: None     Source Type: Journal    
DOI: 10.1002/ccd.20552     Document Type: Review

References (59)

1. Kern MJ, Aguirre F, Bach R, Donohue T, Siegel R, Segal J. Augmentation of coronary blood flow by intra-aortic balloon pumping in patients after coronary angioplasty. Circulation 1993;87:500-511.
2. Mueller H, Ayres SM, Conklin EF, Giannelli S, Jr, Mazzara JT, Grace WT, Nealon TF, Jr. The effects of intra-aortic counterpulsation on cardiac performance and metabolism in shock associated with acute myocardial infarction. J Clin Invest 1971;50:1885-1900.
3. Williams DO, Korr KS, Gewirtz H, Most AS. The effect of intra-aortic balloon counterpulsation on regional myocardial blood flow and oxygen consumption in the presence of coronary artery stenosis in patients with unstable angina. Circulation 1982;66:593-597.
4. Jiang CY, Zhao LL, Wang JA, Mohammod B. Anticoagulation therapy in intra-aortic balloon counterpulsation: does IABP really need anti-coagulation? J Zhejiang Univ Sci 2003;4:607-611.
5. Mahaffey K, Kruse K, Ohman EM. In: Ej T, editor. Perspectives on the use of intra-aortic balloon counterpulsation in the 1990s. Philadelphia: W.B. Saunders; 1996. p 303-320.
6. Baskett RJ, Ghali WA, Maitland A, Hirsch GM. The intraaortic balloon pump in cardiac surgery. Ann Thorac Surg 2002;74:1276-1287.
7. Christenson JT, Simonet F, Badel P, Schmuziger M. Optimal timing of preoperative intraaortic balloon pump support in high-risk coronary patients. Ann Thorac Surg 1999;68:934-939.
8. Kang N, Edwards M, Larbalestier R. Preoperative intraaortic balloon pumps in high-risk patients undergoing open heart surgery. Ann Thorac Surg 2001;72:54-57.
9. Urban PM, Freedman RJ, Ohman EM, Stone GW, Christenson JT, Cohen M, Miller MF, Joseph DL, Bynum DZ, Ferguson JJ, 3rd. In-hospital mortality associated with the use of intra-aortic balloon counterpulsation. Am J Cardiol 2004;94:181-185.
10. Cohen M, Urban P, Christenson JT, Joseph DL, Freedman RJ, Jr, Miller MF, Ohman EM, Reddy RC, Stone GW, Ferguson JJ, 3rd. Intra-aortic balloon counterpulsation in US non-US centres: results of the Benchmark Registry. Eur Heart J 2003;24:1763-1770.
11. Holmes DR, Jr, Detre KM, Williams DO, Kent KM, King SB, 3rd, Yeh W, Steenkiste A. Long-term outcome of patients with depressed left ventricular function undergoing percutaneous transluminal coronary angioplasty. The NHLBI PTCA Registry. Circulation 1993;87:21-29.
12. Arceo A, Urban P, Dorsaz PA, Chatelain P, Verin V, Suilen C, Rombaut E, Chevrolet JC. In-hospital complications of percutaneous intraaortic balloon counterpulsation. Angiology 2003;54:577-585.
13. Cohen M, Ferguson JJ, 3rd, Freedman RJ, Jr, Miller MF, Reddy RC, Ohman EM, Stone GW, Christenson J, Joseph DL. Comparison of outcomes after 8 vs. 9.5 French size intra-aortic balloon counterpulsation catheters based on 9,332 patients in the prospective Benchmark registry. Catheter Cardiovasc Interv 2002;56:200-206.
14. Ferguson JJ, 3rd, Cohen M, Freedman RJ, Jr, Stone GW, Miller MF, Joseph DL, Ohman EM. The current practice of intra-aortic balloon counterpulsation: results from the Benchmark Registry. J Am Coll Cardiol 2001;38:1456-1462.
15. Stone GW, Ohman EM, Miller MF, Joseph DL, Christenson JT, Cohen M, Urban PM, Reddy RC, Freedman RJ, Staman KL, et al. Contemporary utilization and outcomes of intra-aortic balloon counterpulsation in acute myocardial infarction: the benchmark registry. J Am Coll Cardiol 2003;41:1940-1945.
16. Cohen M, Dawson MS, Kopistansky C, McBride R. Sex and other predictors of intra-aortic balloon counterpulsation-related complications: prospective study of 1119 consecutive patients. Am Heart J 2000;139(2 Pt 1):282-287.
17. Nash IS, Lorell BH, Fishman RF, Baim DS, Donahue C, Diver DJ. A new technique for sheathless percutaneous intraaortic balloon catheter insertion. Cathet Cardiovasc Diagn 1991;23:57-60.
18. Tatar H, Cicek S, Demirkilic U, Ozal E, Suer H, Aslan M, Ozturk OY. Vascular complications of intraaortic balloon pumping: unsheathed versus sheathed insertion. Ann Thorac Surg 1993;55:1518-1521.
19. Alderman JD, Gabliani GI, McCabe CH, Brewer CC, Lorell BH, Pastemak RC, Skillman JJ, Steer ML, Baim DS. Incidence and management of limb ischemia with percutaneous wire-guided intraaortic balloon catheters. J Am Coll Cardiol 1987;9:524-530.
20. Rapoport S, Sniderman KW, Morse SS, Proto MH, Ross GR. Pseudoaneurysm: a complication of faulty technique in femoral arterial puncture. Radiology 1985;154:529-530.
21. Bergelson BA, Jacobs AK, Cupples LA, Ruocco NA, Jr, Kyller MG, Ryan TJ, Faxon DP. Prediction of risk for hemodynamic compromise during percutaneous transluminal coronary angioplasty. Am J Cardiol 1992;70:1540-1545.
22. Hartzler GO, Rutherford BD, McConahay DR, Johnson WL, Giorgi LV. "High-risk" percutaneous transluminal coronary angioplasty. Am J Cardiol 1988;61:33G-37G.
23. Stevens T, Kahn JK, McCallister BD, Ligon RW, Spaude S, Rutherford BD, McConahay DR, Johnson WL, Giorgi LV, Shimshak TM, et al. Safety and efficacy of percutaneous transluminal coronary angioplasty in patients with left ventricular dysfunction. Am J Cardiol 1991;68:313-319.
24. Voudris V, Marco J, Morice MC, Fajadet J, Royer T. "High-risk" percutaneous transluminal coronary angioplasty with preventive intra-aortic balloon counterpulsation. Cathet Cardiovasc Diagn 1990;19:160-164.
25. Kahn JK, Rutherford BD, McConahay DR, Johnson WL, Giorgi LV, Hartzler GO. Supported "high risk" coronary angioplasty using intraaortic balloon pump counterpulsation. J Am Coll Cardiol 1990;15:1151-1155.
26. Kreidieh I, Davies DW, Lim R, Nathan AW, Dymond DS, Banim SO. High-risk coronary angioplasty with elective intra-aortic balloon pump support. Int J Cardiol 1992;35:147-152.
27. Briguori C, Sarais C, Pagnotta P, Airoldi F, Liistro F, Sgura F, Spanos V, Carlino M, Montorfano M, Di Mario C, et al. Elective versus provisional intra-aortic balloon pumping in high-risk percutaneous transluminal coronary angioplasty. Am Heart J 2003;145:700-707.
28. Alcan KE, Stertzer SH, Wallsh E, DePasquale NP, Bruno MS. The role of intra-aortic balloon counterpulsation in patients undergoing percutaneous transluminal coronary angioplasty. Am Heart J 1983;105:527-530.
29. Margolis J. Transluminal coronary angioplasty and intracoronary thrombolysis for coronary heart disease. Berlin: Springer-Verlag; 1982.
30. Murphy DA, Craver JM, Jones EL, Curling PE, Guyton RA, King SB, 3rd, Gruentzig AR, Hatcher CR, Jr. Surgical management of acute myocardial ischemia following percutaneous transluminal coronary angioplasty. Role of the intra-aortic balloon pump. J Thorac Cardiovasc Surg 1984;87:332-339.
31. Gold HK, Leinbach RC, Sanders CA, Buckley MJ, Mundth ED, Austen WG. Intraaortic balloon pumping for control of recurrent myocardial ischemia. Circulation 1973;47:1197-1203.
32. Fuchs RM, Brin KP, Brinker JA, Guzman PA, Heuser RR, Yin FC. Augmentation of regional coronary blood flow by intra-aortic balloon counterpulsation in patients with unstable angina. Circulation 1983;68:117-123.
33. Braunwald E, Kloner RA. The stunned myocardium: prolonged, postischemic ventricular dysfunction. Circulation 1982;66:1146-1149.
34. Ohman EM, Califf RM, George BS, Quigley PJ, Kereiakes DJ, Harrelson-Woodlief L, Candela RJ, Flanagan C, Stack RS, Topol EJ for the Thrombolysis and Angioplasty in Myocardial Infarction (TAMI) Study Group. The use of intraaortic balloon pumping as an adjunct to reperfusion therapy in acute myocardial infarction. Am Heart J 1991;121(3 Pt 1):895-901.
35. van't Hof AW, Liem AL, de Boer MJ, Hoomtje JC, Suryapranata H, Zijlstra F. A randomized comparison of intra-aortic balloon pumping after primary coronary angioplasty in high risk patients with acute myocardial infarction. Eur Heart J 1999;20:659-665.
36. Ohman EM, George BS, White CJ, Kern MJ, Gurbel PA, Freedman RJ, Lundergan C, Hartmann JR, Talley JD, Frey MJ, et al. for the Randomized IABP Study Group. Use of aortic counterpulsation to improve sustained coronary artery patency during acute myocardial infarction. Results of a randomized trial. Circulation 1994;90:792-799.
37. Ohman EM, Sigmon K, Samaha J, Stack RS, George BS, Pickel A, Kereiakes D, Lee KL, Califf RM. for the TAMI Study Group. Prediction of reocclusion after successful repurfusion during acute myocardial infarction. [abstract]. J Am Coll Cardiol 1991;17(Suppl A):187A.
38. Ohman EM, Califf R, Topol E, Leimberger JD, George BS, Berrios ED, Anderson L, Kereiakes D, Stack RS. Aortic counterpulsation with thrombolysis for myocardial infarction: salutary effect on reocclusion of the infarct related artery. [abstract]. J Am Coll Cardiol 1992;19(Suppl A):381A.
39. Stone G, Marsalese D, Brodie B, Griffin J, Donohue B, Costantini C, Balestrini C, Wharton T, Jones D, Sachs D, et al. The rountine of intra aortic balloon after primary PTCA improves clinical outcomes in very high risk patients with acute myocardial infarction: Results of the PAMI-2 Trial. [abstract]. Circulation 1995;92(I):139.
40. Stone G, Marsalese D, Brodie B, Griffin J, Donohue B, Costantini C, Balestrini C, Wharton T, Jones D, Sachs D, et al. Is prophylactic IABP use beneficial or harmful in a high risk elderly population with acute myocardial infarction? Results of the PAMI-2 Trial. [abstract]. Circulation 1995;92(I):139.
41. Brodie BR, Stuckey TD, Hansen C, Muncy D. Intra-aortic balloon counterpulsation before primary percutaneous transluminal coronary angioplasty reduces catheterization laboratory events in high-risk patients with acute myocardial infarction. Am J Cardiol 1999;84:18-23.
42. O'Rourke MF, Norris RM, Campbell TJ, Chang VP, Sammel NL. Randomized controlled trial of intraaortic balloon counterpulsation in early myocardial infarction with acute heart failure. Am J Cardiol 1981;47:815-820.
43. Flaherty JT, Becker LC, Weiss JL, Brinker JA, Bulkley BH, Gerstenblith G, Kallman CH, Weisfeldt ML. Results of a randomized prospective trial of intraaortic balloon counterpulsation and intravenous nitroglycerin in patients with acute myocardial infarction. J Am Coll Cardiol 1985;6:434-446.
44. Andersen R, Stebbins A, Bates E, Stomel R, Granger C, Ohman E. Underutilization of aortic counterpulsation in patients with cardiogenic shock: observations for the GUSTO-I Study. [abstract]. Circulation 1995(I):139.
45. Moulopoulos S, Stamatelopoulos S, Petrou P. Intraaortic balloon assistance in intractable cardiogenic shock. Eur Heart J 1986;7:396-403.
46. Stomel RJ, Rasak M, Bates ER. Treatment strategies for acute myocardial infarction complicated by cardiogenic shock in a community hospital. Chest 1994;105:997-1002.
47. Hochman JS, Sleeper LA, Webb JG, Sanborn TA, White HD, Talley JD, Buller CE, Jacobs AK, Slater JN, Col J, et al. for SHOCK Investigators. Early revascularization in acute myocardial infarction complicated by cardiogenic shock. Should we emergently revascularize occluded coronaries for cardiogenic shock? N Engl J Med 1999;341:625-634.
48. French JK, Feldman HA, Assmann SF, Sanborn T, Palmeri ST, Miller D, Boland J, Buller CE, Steingart R, Sleeper LA, et al. Influence of thrombolytic therapy, with or without intra-aortic balloon counterpulsation, on 12-month survival in the SHOCK trial. Am Heart J 2003;146:804-810.
49. Bengtson JR, Kaplan AJ, Pieper KS, Wildermann NM, Mark DB, Pryor DB, Phillips HR, 3rd, Califf RM. Prognosis in cardiogenic shock after acute myocardial infarction in the interventional era. J Am Coll Cardiol 1992;20:1482-1489.
50. Holmes DR, Jr, Bates ER, Kleiman NS, Sadowski Z, Horgan JH, Morris DC, Califf RM, Berger PB, Topol EJ for the GUSTO-I Investigators. Contemporary reperfusion therapy for cardiogenic shock: the GUSTO-I trial experience. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries. J Am Coll Cardiol 1995;26:668-674.
51. Hochman JS, Boland J, Sleeper LA, Porway M, Brinker J, Col J, Jacobs A, Slater J, Miller D, Wasserman H, et al. for SHOCK Registry Investigators. Current spectrum of cardiogenic shock and effect of early revascularization on mortality. Results of an International Registry. Circulation 1995;91:873-881.
52. Sanborn TA, Sleeper LA, Bates ER, Jacobs AK, Boland J, French JK, Dens J, Dzavik V, Palmeri ST, Webb JG, et al. Impact of thrombolysis, intra-aortic balloon pump counterpulsation, and their combination in cardiogenic shock complicating acute myocardial infarction: a report from the SHOCK Trial Registry. Should we emergently revascularize occluded coronaries for cardiogenic shock? J Am Coll Cardiol 2000;36(3 Suppl A):1123-1129.
53. Chen EW, Canto JG, Parsons LS, Peterson ED, Littrell KA, Every NR, Gibson CM, Hochman JS, Ohman EM, Cheeks M, et al. Relation between hospital intra-aortic balloon counterpulsation volume and mortality in acute myocardial infarction complicated by cardiogenic shock. Circulation 2003;108:951-957.
54. Fasseas P, Cohen M, Kopistansky C, Bowers B, McCormick DJ, Kasper K, Christenson JT, Parris TM, Miller MF. Pre-operative intra-aortic balloon counterpulsation in stable patients with left main coronary disease. J Invasive Cardiol 2001;13:679-683.
55. Marra C, De Santo LS, Amarelli C, Della Corte A, Onorati F, Torella M, Nappi G, Cotrufo M. Coronary artery bypass grafting in patients with severe left ventricular dysfunction: a prospective randomized study on the timing of perioperative intraaortic balloon pump support. Int J Artif Organs 2002;25:141-146.
56. Craver JM, Murrah CP. Elective intraaortic balloon counterpulsation for high-risk off-pump coronary artery bypass operations. Ann Thorac Surg 2001;71:1220-1223.
57. Suzuki T, Okabe M, Handa M, Yasuda F, Miyake Y. Usefulness of preoperative intraaortic balloon pump therapy during off-pump coronary artery bypass grafting in high-risk patients. Ann Thorac Surg 2004;77:2056-2059; discussion 2059-2060.
58. Cochran RP, Starkey TD, Panos AL, Kunzelman KS. Ambulatory intraaortic balloon pump use as bridge to heart transplant. Ann Thorac Surg 2002;74:746-751; discussion 751-752.
59. Arafa OE, Geiran OR, Andersen K, Fosse E, Simonsen S, Svennevig JL. Intraaortic balloon pumping for predominantly right ventricular failure after heart transplantation. Ann Thorac Surg 2000;70:1587-1593.